Reference
1. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:1560-99, 2018.
2. Hsu PI, Lai KH, Cheng JS, et al. Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area. Hepatology 62:387-96, 2015.
3. Mahale P, Kontoyiannis DP, Chemaly RF, et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepotol 57:1177-85, 2012.
4. Torres HA, Hosry J, Mahale P, Economides MP, Jiang Y, Lok AS. Hepatitis C Virus Reactivation in Patients Receiving Cancer Treatment: A Prospective Observational Study. Hepatology 67:36-47, 2018.
5. Ozguroglu M, Bilici A, Turna H, Serdengecti S. Reactivation of Hepatitis B Virus Infection with Cytotoxic Therapy in Non-Hodgkin’s Lymphoma. Med Oncol 21:67-72, 2004.
6. McGovern BH, Birch CE, Bowen MJ, et al. Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria. Clin Infect Dis 49:1051-60, 2009.
7. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 347:92-93, 1996.
8. Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E. Severe Heptatitis Related to Chemotherapy in Heptatitis B Virus Carriers with hematologic Malingancies. Cancer 78:2210-5, 1991.
9. Miyashita K, Hongo Y, Nakashima A, et al. Fetal Hepatitis C after Chemotherapy in a Patient with Malignant Lymphoma: Possible Reactivation of Seronegative Occult Hepatitis C Virus Infection Due to Chemotherapy. Intern Med 60:1533-9, 2021.
10. Evans AT, Loeb KR, Shulman HM, et al. Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases. Am J Surg Patho 39:212-20, 2015.
11. Locasciulli A, Bruno B, Alessandrino EP, et al. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant 31:295-300, 2003.
12. Kato T, Okai T, Shiroma T, et al. Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis. Clin Rheumatol 2005; 24: 182-186.
13. Kawano Y, Miyanishi K, Takahashi S, et al. Hepatitis C virus reactivation due to antiemetic steroid therapy during treatment of hepatocellular carcinoma. J Infect Chemother 23:323-5, 2017.
14. Mori N, Imamura M, Takaki S, et al. Hepatitis C Virus (HCV) Reactivation Caused by Steroid Therapy for Dermatomyositis. Intern Med 53:2689-93, 2014.
15. Ciesek S, Steinmann E, Iken M, et al. Glucocorticosteroids in- crease cell entry by hepatitis C virus. Gastroenterology 138:1875-84, 2010.
16. Magy N, Cribier B, Schmitt C, et al. Effects of corticosteroids on HCV infection. Int J Immunopharmacol 21:253-61, 1999.
17. Smith PJ, Suri D. Adrenalectomy to treat reactivated chronic hepatitis B infection in a patient with a steroid-secreting adrenal tumour. BMJ case report 2011:bcr1120103508, 2011.
18. Tashiro R, Ogawa Y, Tominaga T. Rapid Deterioration of Latent HBV Hepatitis during Cushing Disease and Posttraumatic Stress Disorder after Earthquake. J Neurol Surg A 78:407-11, 2016.
19. Tsou PL, Lee HS, Jeng YM, Huang TS. Submassive Liver Necrosis in a Hepatitis B Carrier With Cushing’s Syndrome. J Formos med Assoc101:156-8, 2002.